Patent details
EP1194033 Title: TRANSGENICALLY PRODUCED ANTITHROMBIN III AND MUTANTS THEREOF
Basic Information
- Publication number:
- EP1194033
- PCT Application Number:
- PCT/US/2000/013052
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP009323486
- PCT Publication Number:
- WO/2000/069256
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TRANSGENICALLY PRODUCED ANTITHROMBIN III AND MUTANTS THEREOF
- French Title of Invention:
- ANTITHROMBINE III PRODUITE DE MANIERE TRANSGENIQUE ET MUTANTS DE CELLE-CI
- German Title of Invention:
- TRANSGENE HERGESTELLTE ANTITHROMBIN III UND DEREN MUTANTEN
- SPC Number:
Dates
- Filing date:
- 12/05/2000
- Grant date:
- 19/12/2007
- EP Publication Date:
- 19/12/2007
- PCT Publication Date:
- 23/11/2000
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/04/2002
- EP B1 Publication Date:
- 19/12/2007
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/05/2008
- Expiration date:
- 12/05/2020
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/05/2000
- Name:
- GTC Biotherapeutics Inc.
- Address:
- 175 Crossing Boulevard,, Framingham, MA 01702, United States (US)
Inventor
1
- Name:
- BOURDON Paul, R.
- Address:
- United States (US)
2
- Name:
- MEADE Harry
- Address:
- United States (US)
Priority
- Priority Number:
- 134174 P
- Priority Date:
- 13/05/1999
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A01K 67/00;
| Filing date | Document type | Number of pages |
|---|